ID

22184

Descripción

A Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Rosiglitazone (Extended Release Tablets) on Cerebral Glucose Utilization and Cognition in Subjects With Mild to Moderate Alzheimer's Disease (AD) Medicine: rosiglitazone, Condition: Alzheimer's Disease, Phase: 2, Clinical Study ID: 49653/461, Sponsor: GSK Source & Descriptions: https://clinicaltrials.gov/ct2/show/NCT00265148?term=NCT00265148&rank=1

Link

https://clinicaltrials.gov/ct2/show/NCT00265148?term=NCT00265148&rank=1

Palabras clave

  1. 22/5/17 22/5/17 -
Subido en

22 de mayo de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :


Sin comentarios

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Prior Medication Effects of Rosiglitazone on Cerebral Glucose Utilization and Cognition in Subjects With Alzheimer's Disease NCT00265148

Prior Medication Effects of Rosiglitazone on Cerebral Glucose Utilization and Cognition in Subjects With Alzheimer's Disease NCT00265148

Prior Medication
Descripción

Prior Medication

Alias
UMLS CUI-1
C0013227
Has the patient taken any medication within 1 week PRIOR to the first dose of study medication?
Descripción

Pharmaceutical preparations

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0013227
If ´YES`, please record the medications below.
Descripción

specification

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C2348235
Prior Medication
Descripción

Prior Medication

Alias
UMLS CUI-1
C2826257
Drug name (Trade Name preferred)
Descripción

Drug name

Tipo de datos

text

Alias
UMLS CUI [1]
C0013227
Single Dose/ Unit (e.g. 500mg)
Descripción

Single dose/Unit

Tipo de datos

float

Unidades de medida
  • mg
Alias
UMLS CUI [1,1]
C2826257
UMLS CUI [1,2]
C1960417
mg
Frequency of this Dose (e.g. BID PRN)
Descripción

Frequency

Tipo de datos

text

Alias
UMLS CUI [1]
C3476109
Route
Descripción

Route

Tipo de datos

text

Alias
UMLS CUI [1]
C0013153
Indication
Descripción

Indication

Tipo de datos

text

Alias
UMLS CUI [1,1]
C3146298
UMLS CUI [1,2]
C0013227
End Date
Descripción

End Date

Tipo de datos

date

Unidades de medida
  • Day Month Year
Alias
UMLS CUI [1]
C1531784
Day Month Year
Continuing at end of
Descripción

Continuing

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C1553904

Similar models

Prior Medication Effects of Rosiglitazone on Cerebral Glucose Utilization and Cognition in Subjects With Alzheimer's Disease NCT00265148

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Prior Medication
C0013227 (UMLS CUI-1)
Pharmaceutical preparations
Item
Has the patient taken any medication within 1 week PRIOR to the first dose of study medication?
boolean
C0013227 (UMLS CUI [1])
specification
Item
If ´YES`, please record the medications below.
text
C0013227 (UMLS CUI [1,1])
C2348235 (UMLS CUI [1,2])
Item Group
Prior Medication
C2826257 (UMLS CUI-1)
Drug name
Item
Drug name (Trade Name preferred)
text
C0013227 (UMLS CUI [1])
Single dose/Unit
Item
Single Dose/ Unit (e.g. 500mg)
float
C2826257 (UMLS CUI [1,1])
C1960417 (UMLS CUI [1,2])
Frequency
Item
Frequency of this Dose (e.g. BID PRN)
text
C3476109 (UMLS CUI [1])
Route
Item
Route
text
C0013153 (UMLS CUI [1])
Indication
Item
Indication
text
C3146298 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
End Date
Item
End Date
date
C1531784 (UMLS CUI [1])
Continuing
Item
Continuing at end of
boolean
C0087111 (UMLS CUI [1,1])
C1553904 (UMLS CUI [1,2])

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial